Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
GeoVax Labs, Inc. - Common Stock
(NQ:
GOVX
)
0.5967
-0.0076 (-1.26%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 15, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about GeoVax Labs, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
20
21
Next >
GeoVax Highlights Strong Clinical Results Following Presentation of Multi-Antigen COVID-19 Vaccine at the 25th Annual World Vaccine Congress
April 24, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax Highlights Strong Clinical Results Following Presentation of Multi-Antigen COVID-19 Vaccine at the 25th Annual World Vaccine Congress
April 24, 2025
GEO-CM04S1 Demonstrates Durable T Cell and Antibody Responses in Healthy and Immunocompromised Populations
Via
TheNewswire.com
GeoVax to Report First Quarter 2025 Financial Results and Provide Corporate Update on May 1, 2025
April 23, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax to Report First Quarter 2025 Financial Results and Provide Corporate Update on May 1, 2025
April 23, 2025
GeoVax to Host Conference Call at 4:30 PM ET
Via
TheNewswire.com
GeoVax Appoints Dr. Senthil Ranganathan as Vice President, Technical Development and CMC Operations
April 22, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax Appoints Dr. Senthil Ranganathan as Vice President, Technical Development and CMC Operations
April 22, 2025
Recognized Biologics Executive to Oversee Critical Expansion of U.S.-Based Development Capabilities
Via
TheNewswire.com
What's Next: Geovax Labs's Earnings Preview
March 26, 2025
Via
Benzinga
GeoVax Highlights New Study Demonstrating the Strength of Multi-Antigen COVID-19 Vaccine Candidates
April 16, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax Highlights New Study Demonstrating the Strength of Multi-Antigen COVID-19 Vaccine Candidates
April 16, 2025
Peer-Reviewed Data Reinforces GeoVax’s Multi-Antigen Strategy With GEO-CM02 and Supports Advancement of GEO-CM04S1 Clinical Programs
Via
TheNewswire.com
GeoVax Provides Update on BARDA Project NextGen and Outlines 2025 Business Momentum
April 16, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Top stock movements in today's session.
April 15, 2025
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
Via
Chartmill
Tuesday's session: top gainers and losers
April 15, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
GeoVax to Present at the Emerging Growth Conference on April 16, 2025
April 15, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 15, 2025
Via
Benzinga
The market is filled with gapping stocks in Tuesday's session.
April 15, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.
Via
Chartmill
Crude Oil Moves Lower; Citigroup Posts Upbeat Results
April 15, 2025
Via
Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
April 15, 2025
Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via
Chartmill
Nasdaq Surges 100 Points; Bank of America Earnings Top Views
April 15, 2025
Via
Benzinga
GeoVax to Present Clinical Data at Upcoming April Industry Events
April 15, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 15, 2025
Via
Benzinga
US Stock Futures Waver After Two-Day Rally: Trump's Tariff Moves Could End A 3-Year 'Rolling Recession,' Says Expert
April 15, 2025
U.S. stock futures were volatile on Tuesday following a two-day advance. Futures of major benchmark indices were mixed in premarket.
Via
Benzinga
Topics
Government
Why Ericsson Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
April 15, 2025
Via
Benzinga
Stay updated with the stocks that are on the move in today's after-hours session.
April 14, 2025
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via
Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
April 14, 2025
Via
Benzinga
GeoVax Receives USPTO Notice of Allowance for Marburg Hemorrhagic Fever Vaccine Patent
April 09, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Intellectual Property
GeoVax Receives USPTO Notice of Allowance for Marburg Hemorrhagic Fever Vaccine Patent
April 09, 2025
Continues to Strengthen Its Pandemic Preparedness and Biodefense Vaccine Portfolio
Via
TheNewswire.com
Topics
Intellectual Property
GeoVax Reports 2024 Year-End Financial Results and Provides Business Update
March 27, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax Reports 2024 Year-End Financial Results and Provides Business Update
March 27, 2025
GEO-CM04S1 BARDA/Project NextGen Phase 2b trial preparations ongoing with manufacturing of clinical trial materials underway and clinical sites confirmed
Via
TheNewswire.com
Earnings Scheduled For March 27, 2025
March 27, 2025
Via
Benzinga
GeoVax Labs Announces $4.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
March 24, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Regulatory Compliance
< Previous
1
2
3
4
5
6
7
8
9
...
20
21
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
Starting at $3.75
/
week.
Subscribe Today